Hims & Hers Health (HIMS) Competitors $21.80 -1.73 (-7.35%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends HIMS vs. FMS, SHC, GH, OPCH, BTSG, VCYT, SGRY, LFST, CON, and PACSShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Fresenius Medical Care (FMS), Sotera Health (SHC), Guardant Health (GH), Option Care Health (OPCH), BrightSpring Health Services (BTSG), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and PACS Group (PACS). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Fresenius Medical Care Sotera Health Guardant Health Option Care Health BrightSpring Health Services Veracyte Surgery Partners LifeStance Health Group Concentra Group Holdings Parent PACS Group Fresenius Medical Care (NYSE:FMS) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations. Is FMS or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Fresenius Medical Care's net margin of 3.43%. Hims & Hers Health's return on equity of 10.97% beat Fresenius Medical Care's return on equity.Company Net Margins Return on Equity Return on Assets Fresenius Medical Care3.43% 6.04% 2.69% Hims & Hers Health 8.19%10.97%8.29% Does the MarketBeat Community believe in FMS or HIMS? Fresenius Medical Care received 383 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 54.69% of users gave Fresenius Medical Care an outperform vote while only 37.37% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformFresenius Medical CareOutperform Votes42054.69% Underperform Votes34845.31% Hims & Hers HealthOutperform Votes3737.37% Underperform Votes6262.63% Which has more risk & volatility, FMS or HIMS? Fresenius Medical Care has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500. Which has better earnings and valuation, FMS or HIMS? Fresenius Medical Care has higher revenue and earnings than Hims & Hers Health. Fresenius Medical Care is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresenius Medical Care$21.05B0.61$540.07M$1.2118.01Hims & Hers Health$1.24B3.83-$23.55M$0.4449.55 Does the media prefer FMS or HIMS? In the previous week, Hims & Hers Health had 27 more articles in the media than Fresenius Medical Care. MarketBeat recorded 30 mentions for Hims & Hers Health and 3 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.46 beat Hims & Hers Health's score of 0.26 indicating that Fresenius Medical Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 8 Very Positive mention(s) 6 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in FMS or HIMS? 8.3% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts rate FMS or HIMS? Fresenius Medical Care presently has a consensus target price of $24.30, indicating a potential upside of 11.52%. Hims & Hers Health has a consensus target price of $20.71, indicating a potential downside of 4.98%. Given Fresenius Medical Care's higher possible upside, equities research analysts clearly believe Fresenius Medical Care is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.38 SummaryHims & Hers Health beats Fresenius Medical Care on 11 of the 18 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$4.76B$904.65M$5.00B$19.90BDividend YieldN/AN/A5.21%3.54%P/E Ratio49.559.87130.6642.58Price / Sales3.831.331,201.6918.15Price / CashN/A45.1233.4117.85Price / Book13.547.924.685.66Net Income-$23.55M-$52.07M$118.04M$984.91M7 Day Performance-21.01%-16.04%-2.44%-0.16%1 Month Performance-1.58%-13.43%-4.03%0.18%1 Year Performance181.84%-14.09%29.54%23.71% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health3.5685 of 5 stars$21.80-7.4%$20.71-5.0%+181.8%$5.14B$872M49.551,046Analyst ForecastInsider TradeFMSFresenius Medical Care3.9521 of 5 stars$21.79-1.4%$24.30+11.5%+11.1%$12.79B$21.05B18.011,358Positive NewsSHCSotera Health3.662 of 5 stars$13.21-2.9%$16.50+24.9%-5.2%$3.85B$1.05B52.843,000High Trading VolumeGHGuardant Health4.2798 of 5 stars$30.68flat$40.60+32.3%+28.4%$3.79B$563.95M-7.241,779OPCHOption Care Health4.9784 of 5 stars$21.88+0.3%$30.83+40.9%-26.3%$3.71B$4.30B18.397,802Positive NewsBTSGBrightSpring Health Services2.9593 of 5 stars$18.79+0.8%$16.79-10.6%N/A$3.27B$10.59B-72.2735,000Positive NewsVCYTVeracyte4.1264 of 5 stars$39.20+0.1%$41.25+5.2%+50.5%$3.03B$361.05M-261.33790Analyst ForecastSGRYSurgery Partners3.0975 of 5 stars$22.51-1.1%$38.71+72.0%-29.9%$2.89B$2.74B0.0013,500Analyst ForecastLFSTLifeStance Health Group1.7828 of 5 stars$7.22-0.3%$8.50+17.7%+16.5%$2.77B$1.06B0.009,325CONConcentra Group Holdings ParentN/A$21.27+4.9%$28.50+34.0%N/A$2.71B$1.84B0.0011,000Gap UpHigh Trading VolumePACSPACS Group4.0685 of 5 stars$17.25+0.9%$39.88+131.2%N/A$2.61B$3.11B0.0032,433Analyst Forecast Related Companies and Tools Related Companies FMS Competitors SHC Competitors GH Competitors OPCH Competitors BTSG Competitors VCYT Competitors SGRY Competitors LFST Competitors CON Competitors PACS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HIMS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HIMS Stock Alerts